A literature review supporting the proposed national Australian definition for Staphylococcus aureus bacteraemia
Brett Mitchell A D , Anne Gardner A , Peter Collignon B , Lee Stewart A and Marilyn Cruickshank C
+ Author Affiliations
- Author Affiliations
A School of Nursing, Midwifery and Nutrition, James Cook University, Townsville Campus, Qld 4811, Australia.
B Infectious Diseases Unit, The Canberra Hospital, Canberra, ACT, 2605, Australia.
C Australian Commission on Safety & Quality in Healthcare, Level 7, 1 Oxford Street, Darlinghurst, Sydney, NSW, Australia.
D Corresponding author. Email: brett.mitchell@jcu.edu.au
Healthcare Infection 15(4) 105-113 https://doi.org/10.1071/HI10030
Submitted: 26 August 2010 Accepted: 24 November 2010 Published: 20 December 2010
Abstract
Staphylococcus aureus bacteraemia (SAB) is a major cause of morbidity and mortality. During 2009, a national surveillance definition for SAB was developed through the Australian Commission on Safety and Quality in Healthcare (ACSQHC). The aim of this paper is to review the literature surrounding SAB surveillance and in doing so, evaluate the recently developed Australian national definition for SAB. The issues examined in this paper that relate to SAB surveillance include detection, the management of duplicates, classification and acquisition of SAB. Upon reviewing the literature, it was clear that the national Australian SAB surveillance definitions developed by the ACSQHC Healthcare Associated Infection Surveillance Committee are consistent with the majority of literature. Where inconsistencies exist, for example the lack of acquisition information in SAB surveillance programs in the United Kingdom, it is clear that the Australian surveillance definitions are more robust and provide more useful information. The national surveillance definitions for SAB developed by the ACSQHC surveillance committee sets an improved standard for other countries.
References
[1] Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46 1000–8. [see comment]| Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia.Crossref | GoogleScholarGoogle Scholar | 18444816PubMed |
[2] Wyllie DH, Crook DW, Peto TEA. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study. BMJ 2006; 333 281–4. [corrected] [published erratum appears in BMJ 2006 Sep 2;333(7566):468]
| Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study.Crossref | GoogleScholarGoogle Scholar | 16798756PubMed |
[3] Whitby M, McLaws M, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001; 175 264–7.
| 1:STN:280:DC%2BD3MrktVygtg%3D%3D&md5=4aa24c8e9eb153da764a175955828df6CAS | 11587259PubMed |
[4] Collignon P, Nimmo G, Gottlieb T, Gosbell I, Australian Group on Antimicrobial Resistance. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 2005; 11 554–61.
| 15829193PubMed |
[5] Turnidge J, Kotsanas D, Munckhof W, Roberts S, Bennett C, Nimmo G, et al Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 2009; 191 368–73.
| 19807625PubMed |
[6] Cruickshank M, Jorm C. Introduction. In Cruickshank M, Ferguson, J., eds. Reducing Harm to Patients from Healthcare Associated Infection: The Role of Surveillance. Sydney: Australian Commission on Safety & Quality in Healthcare; 2008. pp. 19–25.
[7] Chang F-Y, Peacock Jr JE, Musher DM, Triplett P, MacDonald BB, Mylotte JM, et al Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine 2003; 82 333–9.
| Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3sXnvVCnsLw%3D&md5=e460c7313d4ab7e65480d5ad4b487811CAS | 14530782PubMed |
[8] de Oliveira Conterno L, Wey S, Castelo A. Staphylococcus aureus bacteremia: comparison of two periods and a predictive model of mortality. Braz J Infect Dis 2002; 6 288–97.
| 12585972PubMed |
[9] Health Protection Agency. Mandatory Staphylococcus aureus bacteraemia surveillance scheme. London: Health Protection Agency; 2009 [2nd September 2009]; Available from: http://www.hpa.org.uk/web/HPAweb&Page&HPAwebAutoListName/Page/1191942169773.
[10] Lyytikäinen O, Ruotsalainen E, Jarvinen A, Valtonen V, Ruutu P. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995–2001. Eur J Clin Microbiol Infect Dis 2005; 24 399–404.
| Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995–2001.Crossref | GoogleScholarGoogle Scholar | 15931453PubMed |
[11] Rezende N, Blumberg H, Metzger B, Larsen N, Ray S, McGowan J. Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci 2002; 323 117–23.
| Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission.Crossref | GoogleScholarGoogle Scholar | 11908855PubMed |
[12] South Australian Infection Control Service. Bloodstream infection definitions. Adelaide: Government of South Australia 2006 [cited 2009 2nd September 2009]; Available from: http://www.health.sa.gov.au/INFECTIONCONTROL/Default.aspx?tabid=24.
[13] Tacconelli E, Venkataraman L, De Girolami PC, Dagata EMC. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. J Antimicrob Chemother 2004; 53 474–9.
| Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2cXhvFSrtrk%3D&md5=ccbcf107ea84f31bd3398f64c14d6547CAS | 14762054PubMed |
[14] Collignon P, Dreimanis D, Ferguson J, van Gessel H, Taylor P, Wilkinson I. et al. Bloodstream Infection. In Cruickshank M, Ferguson, J., eds. Reducing harm to patients from healthcare associated infections: the role of surveillance. Sydney: Australian Commission on Safety and Quality in Health Care; 2008. pp. 53–89.
[15] Cordova SP, Heath CH, McGechie DB, Keil AD, Beers MY, Riley TV. Methicillin-resistant Staphylococcus aureus bacteraemia in Western Australian teaching hospitals, 1997–1999: risk factors, outcomes and implications for management. J Hosp Infect 2004; 56 22–8.
| Methicillin-resistant Staphylococcus aureus bacteraemia in Western Australian teaching hospitals, 1997–1999: risk factors, outcomes and implications for management.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2c%2FhtVWjtQ%3D%3D&md5=43d3259dde754949bd12f3648fce110dCAS | 14706267PubMed |
[16] Collignon P, Wilkinson I, Gilbert G, Grayson L, Whitby M. Health care-associated Staphylococcus aureus bloodstream infections: a clinical quality indicator for all hospitals. Med J Aust 2006; 184 404–6.
| 16618240PubMed |
[17] Mitchell B, McGregor A, Wells A. Staphylococcus aureus bacteraemia surveillance protocol In Unit TIPaC, ed. 2.0 ed: Department of Health and Human Services, Hobart; 2009.
[18] Staph. aureus blood stream infection surveillance [database on the Internet]. National Public Health Service for Wales. 2009 [cited 3rd September 2009]. Available from: http://www.wales.nhs.uk/sites3/page.cfm?orgid=379&pid=13124.
[19] Health Protection Agency. Mandatory Enhanced MRSA Surveillance Protocol. In Agency HP, editor. Version 1 ed: Health Protection Agency; 2005.
[20] Expert Working Group in surveillance of the Australian Infection Control Association. Introduction to Australian surveillance definitions: surgical site infections and blood-stream infections. Aust Infect Control 2000; 5 25–31.
[21] Health Protection Scotland. Scottish Surveillance of Healthcare Associated Infection Programme Quarterly report on Staphylococcus aureus bacteraemias in Scotland. Health Protection Scotland; 2009 [cited 2009 1st October 2009]; Available from: http://www.hps.scot.nhs.uk/haiic/ic/wrdetail.aspx?id=41928&wrtype=6.
[22] Friedman N, Kaye K, Stout J, McGarry S, Trivette S, Briggs J, et al Health Care–Associated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections. Ann Intern Med 2002; 137 791–7.
| 12435215PubMed |
[23] Lesens O, Hansmann Y, Brannigan E, Hopkins S, Meyer P, O’Connel B, et al Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate? Infect Control Hosp Epidemiol 2005; 26 204–9.
| Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate?Crossref | GoogleScholarGoogle Scholar | 15756893PubMed |
[24] Horan T, Andrus M, Dudeck M. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36 309–32.
| CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting.Crossref | GoogleScholarGoogle Scholar | 18538699PubMed |
[25] Chaves F, García-Martínez J, de Miguel S, Sanz F, Otero JR. Epidemiology and clonality of methicillin-resistant and methicillin-susceptible Staphylococcus aureus causing bacteremia in a tertiary-care hospital in Spain. Infect Control Hosp Epidemiol 2005; 26 150–6.
| Epidemiology and clonality of methicillin-resistant and methicillin-susceptible Staphylococcus aureus causing bacteremia in a tertiary-care hospital in Spain.Crossref | GoogleScholarGoogle Scholar | 15756885PubMed |
[26] Burke RE, Halpern MS, Baron EJ, Gutierrez K. Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome. Infect Control Hosp Epidemiol 2009; 30 636–44.
| Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome.Crossref | GoogleScholarGoogle Scholar | 19496643PubMed |
[27] Jeyaratnam D, Edgeworth JD, French GL. Enhanced surveillance of meticillin-resistant Staphylococcus aureus bacteraemia in a London teaching hospital. J Hosp Infect 2006; 63 365–73.
| Enhanced surveillance of meticillin-resistant Staphylococcus aureus bacteraemia in a London teaching hospital.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD28vit1ahtw%3D%3D&md5=bbb165b59a8d9b9970028a293df56f3fCAS | 16765481PubMed |
[28] Dreimanis D, Beckingham W, Collignon P, Roberts J. Staphylococcus aureus bacteraemia surveillance: a relatively easy to collect but accurate clinical indicator on serious health-care associated infections and antibiotic resistance. Aust Infect Control 2005; 10 127–30.
[29] Nickerson EK, Hongsuwan M, Limmathurotsakul D, Wuthiekanun V, Shah KR, Srisomang P, et al Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS ONE 2009; 4 e4308 [Electronic Resource]
| Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance.Crossref | GoogleScholarGoogle Scholar | 19180198PubMed |
[30] Turnidge JD, Nimmo GR, Pearson J, Gottlieb T, Collignon PJ. Australian Group on Antimicrobial R. Epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005–06: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell 2007; 31 398–403.
| 18268881PubMed |
[31] Perovic O, Koornhof H, Black V, Moodley I, Duse A, Galpin J. Staphylococcus aureus bacteraemia at two academic hospitals in Johannesburg. South African Medical Journal Suid-Afrikaanse Tydskrif Vir Geneeskunde. 2006; 96 714–7.
| 17019494PubMed |
[32] Guilarde AO, Turchi MD, Martelli CMT, Primo MGB. Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital. J Hosp Infect 2006; 63 330–6.
| Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD28zlt1Cmtw%3D%3D&md5=9c84ba9ba59edd12c835f618e9e37f84CAS | 16713018PubMed |
[33] Johnson LB, Bhan A, Pawlak J, Manzor O, Saravolatz LD. Changing epidemiology of community-onset methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2003; 24 431–5.
| Changing epidemiology of community-onset methicillin-resistant Staphylococcus aureus bacteremia.Crossref | GoogleScholarGoogle Scholar | 12828320PubMed |
[34] Khairulddin N, Bishop L, Lamagni TL, Sharland M, Duckworth G. Emergence of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia among children in England and Wales, 1990–2001. Arch Dis Child 2004; 89 378–9.
| Emergence of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia among children in England and Wales, 1990–2001.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2c7jvF2rtg%3D%3D&md5=ccce2f1a7918a05750cbddfd66a13593CAS | 15033852PubMed |
[35] Lin J-C, Yeh K-M, Peng M-Y, Chang F-Y. Community-acquired methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: risk factors for acquisition, clinical features and outcome. J Microbiol Immunol Infect 2004; 37 24–8.
| 15060683PubMed |
[36] Lin C, Wang J, Lin C, Chen S, Wang J, Wu K, et al Methicillin-resistant Staphylococcus aureus bacteremia in patients with end-stage renal disease in Taiwan: distinguishing between community-associated and healthcare-associated strains. Infect Control Hosp Epidemiol 2009; 30 89–92.
| Methicillin-resistant Staphylococcus aureus bacteremia in patients with end-stage renal disease in Taiwan: distinguishing between community-associated and healthcare-associated strains.Crossref | GoogleScholarGoogle Scholar | 19046055PubMed |
[37] Chia JW-Z, Hsu L-Y, Chai LY-A, Tambyah PA. Epidemiology and outcomes of community-onset methicillin-susceptible Staphylococcus aureus bacteraemia in a university hospital in Singapore. BMC Infect Dis 2008; 8 14
| Epidemiology and outcomes of community-onset methicillin-susceptible Staphylococcus aureus bacteraemia in a university hospital in Singapore.Crossref | GoogleScholarGoogle Scholar | 18254979PubMed |
[38] O’Connell B, McMahon G, Kelleher M, Rossney AS. Meticillin-resistant Staphylococcus aureus blood-stream infection among patients attending the emergency department of an urban tertiary-referral hospital. Ir Med J 2007; 100 433–5. [see comment]
| 1:STN:280:DC%2BD2szltlCgtw%3D%3D&md5=b81d4a336bc02a392d2ee64952ab1fd4CAS | 17566479PubMed |
[39] Canadian Nosocomial Infection Surveillance Program. Surveillance for Methicillin-resistant Staphylococcus aureus (MRSA) in Patients Hospitalized in Canadian Acute-Care Hospitals Participating in CNISP 2006–2007 Preliminary Results Public Health Agency of Canada; 2008 [2nd October 2009]; Available from: http://www.phac-aspc.gc.ca/nois-sinp/pdf/mrsa-sarm-eng.pdf.
[40] Lesse AJ, Mylotte JM. Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia. Am J Infect Control 2006; 34 642–50.
| Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.Crossref | GoogleScholarGoogle Scholar | 17161739PubMed |
[41] Coello R, Charlett A, Ward V, Wilson J, Pearson A, Sedgwick J, et al Device-related sources of bacteraemia in English hospitals–opportunities for the prevention of hospital-acquired bacteraemia. J Hosp Infect 2003; 53 46–57. [see comment]
| Device-related sources of bacteraemia in English hospitals–opportunities for the prevention of hospital-acquired bacteraemia.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD38jjtl2lsA%3D%3D&md5=2b6a4ce2b4408b20f2e3107a28094ab8CAS | 12495685PubMed |
[42] Munckhof WJ. Intravenous catheter-associated Staphylococcus aureus bacteraemia: a common problem that can be prevented. Intern Med J 2005; 35 315–8.
| Intravenous catheter-associated Staphylococcus aureus bacteraemia: a common problem that can be prevented.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2M3ltlKrug%3D%3D&md5=95ac6d7b1aa86f17e2b58fb2e4e39ceeCAS | 15892759PubMed |
[43] O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2002; 30 476–89.
| Guidelines for the prevention of intravascular catheter-related infections.Crossref | GoogleScholarGoogle Scholar | 12461511PubMed |
[44] Collignon P, Dreimanis D, Beckingham W, Roberts J, Gardner A. Intravascular catheter bloodstream infections: an effective and sustained hospital-wide prevention program over 8 years. Med J Aust 2007; 187 551–4.
| 18021041PubMed |
[45] Saginur R, Suh KN. Staphylococcus aureus bacteraemia of unknown primary source: where do we stand? Int J Antimicrob Agents 2008; 32 S21–5.
| Staphylococcus aureus bacteraemia of unknown primary source: where do we stand?Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXht1KmurvI&md5=60069c29ae58ea31424021d9c37ce8f6CAS | 18757183PubMed |
[46] CHRISP. Surveillance Manual. Queensland Government; 2009 [cited 2009 2nd September 2009]; 3rd: [Available from: http://www.health.qld.gov.au/chrisp/surveillance/surveillance_manual.asp.
[47] Healthcare Associated Infection Unit. Surveillance Manual. Perth: Department of Health Western Australia; 2009 [3rd September 2009]; Version 3: [Available from: http://www.public.health.wa.gov.au/cproot/813/2/Revised%20Surveillance%20Manual%20July2009.pdf